382 related articles for article (PubMed ID: 29440144)
21. PDLIM1 Inhibits Tumor Metastasis Through Activating Hippo Signaling in Hepatocellular Carcinoma.
Huang Z; Zhou JK; Wang K; Chen H; Qin S; Liu J; Luo M; Chen Y; Jiang J; Zhou L; Zhu L; He J; Li J; Pu W; Gong Y; Li J; Ye Q; Dong D; Hu H; Zhou Z; Dai L; Huang C; Wei X; Peng Y
Hepatology; 2020 May; 71(5):1643-1659. PubMed ID: 31509262
[TBL] [Abstract][Full Text] [Related]
22. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
23. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
24. Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways.
Shi C; Cai Y; Li Y; Li Y; Hu N; Ma S; Hu S; Zhu P; Wang W; Zhou H
Redox Biol; 2018 Apr; 14():59-71. PubMed ID: 28869833
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
[TBL] [Abstract][Full Text] [Related]
26. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
27. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
28. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
29. An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin.
Wu Y; Zhao Y; Huan L; Zhao J; Zhou Y; Xu L; Hu Z; Liu Y; Chen Z; Wang L; Huang S; He X; Liang L
Cancer Res; 2020 Mar; 80(5):976-987. PubMed ID: 31874857
[TBL] [Abstract][Full Text] [Related]
30. A novel mechanism of the M1-M2 methionine adenosyltransferase switch-mediated hepatocellular carcinoma metastasis.
Wang R; Jin Y; Yao XH; Fan W; Zhang J; Cao Y; Li J
Mol Carcinog; 2018 Sep; 57(9):1201-1212. PubMed ID: 29749642
[TBL] [Abstract][Full Text] [Related]
31. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
33. miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2.
Han LL; Yin XR; Zhang SQ
Int J Oncol; 2018 Dec; 53(6):2433-2444. PubMed ID: 30272278
[TBL] [Abstract][Full Text] [Related]
34. Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells.
Liang L; Li Q; Huang LY; Li DW; Wang YW; Li XX; Cai SJ
Int J Oncol; 2014 Aug; 45(2):659-66. PubMed ID: 24859471
[TBL] [Abstract][Full Text] [Related]
35. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
[TBL] [Abstract][Full Text] [Related]
36. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
[TBL] [Abstract][Full Text] [Related]
37. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
Yang J; Xing Z
Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
[TBL] [Abstract][Full Text] [Related]
38. Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma.
Guo Q; Wang J; Cao Z; Tang Y; Feng C; Huang F
Int J Oncol; 2018 Aug; 53(2):592-602. PubMed ID: 29901195
[TBL] [Abstract][Full Text] [Related]
39. Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade.
Yu H; Shen Y; Jin J; Zhang Y; Feng T; Liu X
Cell Adh Migr; 2018 Jan; 12(1):56-68. PubMed ID: 28636424
[TBL] [Abstract][Full Text] [Related]
40. Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.
Serizawa N; Tian J; Fukada H; Baghy K; Scott F; Chen X; Kiss Z; Olson K; Hsu D; Liu FT; Török NJ; Zhao B; Jiang JX
Lab Invest; 2015 Oct; 95(10):1145-56. PubMed ID: 26146960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
